Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery

Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery: A Pilot Study

The overall objective of this pilot study is to test a comprehensive nutritional intervention in elderly patients diagnosed with hip fracture, which the study team believe will reduce functional decline, morbidity and mortality.

Study Overview

Status

Completed

Conditions

Detailed Description

This collaborative pilot study is led by a PI who is a board-certified orthopaedic surgeon with extensive experience in the care of older adults with hip fractures. In addition, the multidisciplinary study team includes a research health scientist with vast experience in nutrition, preventive health, and gerontology. The study team will also be supported by a physical therapist and researcher in the field of rehabilitation of older adults with musculoskeletal disorders. Furthermore, an occupational therapist with expertise in rehabilitation science, conduct of pilot studies, and analysis of interview data will play an important role in this study. Moreover, the statistical analyses will be performed by an expert statistical consultant from our institution, who will be reimbursed on a fee for service basis.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • San Antonio, Texas, United States, 78229
        • University Health System
      • San Antonio, Texas, United States, 78229
        • UT Health San Antonio Department of Orthopedics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Provision of signed and dated informed consent form
  2. Male or female, aged 65-89 years
  3. Closed fracture of the proximal femur including the anatomic areas of femoral neck, intertrochanteric and subtrochanteric region
  4. Patient indicated for surgical treatment (surgical fixation or arthroplasty) as per orthopaedic surgeon
  5. Ability to take oral medication and be willing to adhere to the study drug regimen and to the nutritional guidance provided by nutritional experts.

Exclusion Criteria:

  1. Patients with open fractures
  2. Surgical treatment other than surgical fixation or arthroplasty, such as proximal femur resection
  3. Known allergic reactions to components of the study drugs or who do not tolerate oral nutritional supplementation (e.g. total parenteral nutrition or food allergies)
  4. Decisional impairment
  5. Prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nutritional Supplements
Juven and Centrum Silver 50+ will be administered to this group
Nutritional supplements
Other Names:
  • Conditionally essential amino acids
Over the counter nutritional supplement
Other Names:
  • Multivitamin/multimineral
No Intervention: Control
Standard of care procedures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of surgical complications at 26 weeks
Time Frame: 26 weeks (post surgery)
Number of subjects that experienced any complications post surgery
26 weeks (post surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital Readmissions
Time Frame: 26 weeks (post surgery)
Number of hospital re-admissions
26 weeks (post surgery)
Secondary fractures
Time Frame: 26 weeks (post surgery)
Number of secondary fractures that occurred post surgery
26 weeks (post surgery)
Grip strength
Time Frame: Baseline to 26 weeks
Change in grip strength from pre- to post-surgery using a hand dynamometer and measured in pounds
Baseline to 26 weeks
Quality of Life Survey (Short-form 36 Health (SF-36))
Time Frame: Baseline to 26 weeks
Change in Health related quality of life (QOL) survey, a 36 item survey. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
Baseline to 26 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Boris Zelle, MD, University of Texas Health Science Center San Antonio

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2023

Primary Completion (Actual)

December 10, 2024

Study Completion (Actual)

June 4, 2025

Study Registration Dates

First Submitted

July 14, 2023

First Submitted That Met QC Criteria

July 31, 2023

First Posted (Actual)

August 2, 2023

Study Record Updates

Last Update Posted (Estimated)

October 14, 2025

Last Update Submitted That Met QC Criteria

October 13, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HSC20230182H
  • 5P30AG044271 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected deidentified IPD, that underlie results in a publication

IPD Sharing Time Frame

At the time of publication in a peer reviewed journal

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Juven

Subscribe